Internal Medicine NewsAsthma treatment does not appear to raise risk of neuropsychiatric diseaseJanuary 4, 2022AsthmaNeurologyMixed TopicsMental Health
Internal Medicine NewsFDA approves cabotegravir LA; New HIV PrEP option fills an important gapDecember 21, 2021Infectious DiseasesAsthma
Internal Medicine NewsFDA approves tezepelumab-ekko (Tezspire) for severe asthmaDecember 20, 2021Asthma
Internal Medicine NewsCOVID-19 has brought more complex, longer office visitsNovember 5, 2021COVID-19 UpdatesBusiness of MedicinePulmonologyMixed TopicsDiabetesCardiologyMental Health
Internal Medicine NewsPlacebo beat risankizumab in adults with severe asthmaOctober 28, 2021AsthmaMixed TopicsPulmonology
Internal Medicine NewsSynthetic chemical in consumer products linked to early death, study saysOctober 12, 2021EndocrinologyPreventive CareAsthmaMixed Topics
Internal Medicine NewsEAACI review urges reduction in antibiotic overuse with allergyAugust 27, 2021PulmonologyMixed TopicsAsthma
Internal Medicine NewsTezepelumab reduces serious exacerbations in severe asthmaMay 25, 2021AsthmaPulmonology
Internal Medicine NewsList of COVID-19 high-risk comorbidities expandedApril 6, 2021COVID-19 UpdatesAsthma
Internal Medicine NewsAsthma-COPD overlap linked to occupational pollutantsMarch 8, 2021AsthmaPulmonology
Internal Medicine NewsNovel agent shows promise against cat allergyMarch 2, 2021AsthmaPulmonologyPulmonology
Internal Medicine NewsMepolizumab reduced exacerbations in patients with asthma and atopy, depression comorbiditiesMarch 2, 2021AsthmaObesityDepression
Internal Medicine NewsPatients with asthma say most doctors don’t ask about cannabis useMarch 1, 2021AsthmaPulmonology
Internal Medicine NewsAsthma not an independent risk factor for severe COVID-19, hospitalizationFebruary 28, 2021AsthmaCOVID-19 UpdatesPulmonology
